TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 73.50
-0.20 (-0.27%)
Jun 18, 2026, 1:30 PM CST
TTY Biopharm Company Market Cap
TTY Biopharm Company has a market cap or net worth of 18.28 billion as of June 18, 2026. Its market cap has decreased by -2.13% in one year.
Market Cap
18.28B
Enterprise Value
16.81B
Revenue
6.51B
Ranking
n/a
PE Ratio
11.36
Stock Price
73.50
Market Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 18.28B, an increase of 499.37%. That is a compound annual growth rate of 8.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 18.28B | -9.82% |
| Dec 31, 2025 | 20.26B | 11.95% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 52.54B |
| Lotus Pharmaceutical | 50.85B |
| Center Laboratories | 27.66B |
| ScinoPharm Taiwan | 16.76B |
| Synmosa Biopharma | 15.41B |
| YungShin Global Holding | 15.24B |
| Grape King Bio | 14.77B |
| Foresee Pharmaceuticals | 12.41B |